0001567619-19-023466.txt : 20191219 0001567619-19-023466.hdr.sgml : 20191219 20191219200919 ACCESSION NUMBER: 0001567619-19-023466 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191217 FILED AS OF DATE: 20191219 DATE AS OF CHANGE: 20191219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAWLIS V BRYAN CENTRAL INDEX KEY: 0001247681 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 191297462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2019-12-17 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001247681 LAWLIS V BRYAN C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949 1 0 0 0 Common Stock 2019-12-17 4 M 0 3750 21.51 A 27340 D Common Stock 2019-12-17 4 S 0 3750 83.36 D 23590 D Stock Option (Right to buy Common Stock) 21.510 2019-12-17 4 M 0 3750 0 D 2010-11-12 2020-05-11 Common Stock 3750 3750 D Trade made pursuant to a 10b5-1 plan executed on May 1, 2019. Reflects the number of options outstanding after the transactions from the specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2019-12-19